ALLOGENEIC MAMMALIAN ENGINEERED BIOLOGICAL TISSUE

Brand Owner Address Description
ROBOTIC TISSUE Repairon GmbH Rudolf-Wissell-Str. 28a Göttingen 37079 Germany Allogeneic mammalian engineered biological tissue, in particular cultivated tissue with cardiac tissue for treating cardiac insufficiency; biological cultivated cardiac tissue of stem cells for treating cardiac insufficiency; biological cultivated liver tissue intended for subsequent implantation; biological cultivated kidney tissue for medical purposes; biological cultivated brain tissue intended for subsequent implantation; biological cultivated pancreatic tissue intended for subsequent implantation; biological cultivated lung tissue intended for subsequent implantation; biological cultivated muscle tissue intended for subsequent implantation; biological cultivated gastrointestinal tissue intended for subsequent implantation; biological cultivated neuronal tissue intended for subsequent implantation; biological cultivated skin tissue intended for subsequent implantation; biological cultivated bone tissue intended for subsequent implantation; biological cultivated bone marrow intended for subsequent implantation; biological cultivated fat tissue intended for subsequent implantation; biological cultivated connective tissue or biological cultivated blood vessel tissue, all intended for subsequent implantation; Gene therapy products, namely, genetically engineered living tissues for transplant purposes;TISSUE;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. The invention is directed to tissue-engineered biografts, methods for preparing the biografts of the invention, and methods for repairing a damaged myocardium in a mammal. The methods of the invention can include providing a three-dimensional porous polysaccharide matrix; introducing mammalian cells into said matrix; growing said cells in said matrix in vitro, until a tissue-engineered biograft is formed; and transplanting the tissue-engineered biograft onto myocardial tissue or myocardial scar tissue of said mammal. The tissue-engineered biograft of the invention can form a contracting tissue. The methods of the invention can optionally include removing scar tissue or dead tissue from the site of implantation prior to transplanting the biograft.